Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)

CUSIP: 90400D108

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
95,654,006
Total 13F shares
79,925,459
Share change
-349,850
Total reported value
$3,729,060,008
Put/Call ratio
41%
Price per share
$46.69
Number of holders
268
Value change
-$19,184,689
Number of buys
149
Number of sells
95

Quarterly Holders Quick Answers

What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2024

As of 31 Mar 2024, Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by 268 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 79,925,459 shares. The largest 10 holders included VANGUARD GROUP INC, RTW INVESTMENTS, LP, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, SANDS CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Clearbridge Investments, LLC, ALKEON CAPITAL MANAGEMENT LLC, and FEDERATED HERMES, INC.. This page lists 269 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.